Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment
Anne Rentoumis Cappola(University Hospital of Bern), Paul W. Ladenson(Johns Hopkins University), Cheryl L. McDonald(National Heart Lung and Blood Institute), George Sopko(National Heart Lung and Blood Institute), Steven Goldman(University of Arizona), Peter J. Kudenchuk(Public Health – Seattle & King County), Anthony N. Hollenberg(Boston Medical Center), Glenn I. Fishman(New York University), David S. Cooper(Johns Hopkins University), Samia Mora(Brigham and Women's Hospital), Akshay S. Desai(Brigham and Women's Hospital), Lawton S. Cooper(Atrium Health Wake Forest Baptist), Debra Egan(National Institutes of Health), Marco Medici(Radboud University Nijmegen)
Cited by 99
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
Part 8: Adult Advanced Cardiovascular Life Support
|Circulation|2010|1.6k
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
|New England Journal of Medicine|2018|1.6k